156 related articles for article (PubMed ID: 8628371)
1. Intensity of hemodialysis and response to erythropoietin.
Kotanko P
N Engl J Med; 1996 Jun; 334(25):1670; author reply 1670-1. PubMed ID: 8628371
[No Abstract] [Full Text] [Related]
2. Intensity of hemodialysis and response to erythropoietin.
Uréna P; Pétrover M
N Engl J Med; 1996 Jun; 334(25):1669; author reply 1670-1. PubMed ID: 8628368
[No Abstract] [Full Text] [Related]
3. Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients.
Teruel JL; Fernandez Juarez G; Marcen R; Nogueira J; Ortuño J
Nephron; 1996; 73(1):113. PubMed ID: 8742977
[No Abstract] [Full Text] [Related]
4. Intensity of hemodialysis and response to erythropoietin.
Malhotra D; Tzamaloukas AH
N Engl J Med; 1996 Jun; 334(25):1669-70; author reply 1670-1. PubMed ID: 8628369
[No Abstract] [Full Text] [Related]
5. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
von Appen K; Klinkmann H
Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
[No Abstract] [Full Text] [Related]
6. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
7. [Hyporesponsiveness to recombinant human erythropoietin therapy in anemic patients on hemodialysis].
Maeda H; Hirakata H
Nihon Rinsho; 2004 Jun; 62 Suppl 6():307-11. PubMed ID: 15250314
[No Abstract] [Full Text] [Related]
8. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
[No Abstract] [Full Text] [Related]
9. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
11. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
[No Abstract] [Full Text] [Related]
12. [Recurrence of anemia after discontinuation of erythropoietin substitution].
Jelkmann W
Dtsch Med Wochenschr; 1991 Jul; 116(28-29):1127. PubMed ID: 2065604
[No Abstract] [Full Text] [Related]
13. European best practice guidelines 14-16: inadequate response to epoetin.
Hörl WH; Jacobs C; Macdougall IC; Valderrábano F; Parrondo I; Thompson K; Carveth BG
Nephrol Dial Transplant; 2000; 15 Suppl 4():43-50. PubMed ID: 11052148
[No Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients.
Dhondt AW; Vanholder RC; Ringoir SM
Nephrol Dial Transplant; 1995 Nov; 10(11):2107-9. PubMed ID: 8643177
[No Abstract] [Full Text] [Related]
15. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki M; Uday K; Henriquez M; Blum S; Dave M
Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
[No Abstract] [Full Text] [Related]
17. Erythropoietic changes in chronic hemodialysis patients undergoing recombinant human erythropoietin therapy.
Yoshida Y; Ohmori S; Tohyama K; Uchino H; Sawanishi K; Itoh M; Sohma T; Kuze M
Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1092-6. PubMed ID: 3201902
[No Abstract] [Full Text] [Related]
18. Angiotensin converting enzyme inhibitor induced anemia in a kidney transplant recipient.
Kuriyama R; Kogure H; Itoh S; Kikuchi K; Ichikawa N; Nomura Y; Degawa H; Meigata K; Watanabe K; Beck Y; Tomikawa S; Nagao T; Uchida H
Transplant Proc; 1996 Jun; 28(3):1635. PubMed ID: 8658817
[No Abstract] [Full Text] [Related]
19. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance?
Cruz DN; Perazella MA; Abu-Alfa AK; Mahnensmith RL
Am J Kidney Dis; 1996 Oct; 28(4):535-40. PubMed ID: 8840943
[TBL] [Abstract][Full Text] [Related]
20. Selected research topics.
Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):96-104. PubMed ID: 1951363
[No Abstract] [Full Text] [Related]
[Next] [New Search]
